DAVID M MOTT Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for DAVID M MOTT.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of DAVID M MOTT. DAVID M MOTT is a Vice Chairman and CEO in MEDIMMUNE INC /DE ($MEDI) and a Director in NOVAVAX INC ($NVAX) and a 10% Owner in ARCA biopharma, Inc. ($ABIO) and a 10% Owner in INTERLEUKIN GENETICS INC ($ILIU) and a 10% Owner in Achaogen Inc ($AKAO) and a 10% Owner in AVEO PHARMACEUTICALS INC ($AVEO) and a 10% Owner in MULESOFT, INC ($MULE) and a 10% Owner in Tracon Pharmaceuticals, Inc. ($TCON) and a 10% Owner in Cascadian Therapeutics, Inc. ($CASC) and a 10% Owner in Care.com Inc ($CRCM) and a Director in ARDELYX, INC. ($ARDX) and a 10% Owner in APPIAN CORP ($APPN) and a Director in Mersana Therapeutics, Inc. ($MRSN) and a 10% Owner in GENOCEA BIOSCIENCES, INC. ($GNCA) and a 10% Owner in Roka BioScience, Inc. ($ROKA) and a 10% Owner in Ra Pharmaceuticals, Inc. ($RARX) and a Director in TESARO, Inc. ($TSRO) and a 10% Owner in Regulus Therapeutics Inc. ($RGLS) and a 10% Owner in Mirna Therapeutics, Inc. ($MIRN) and a 10% Owner in Cerecor Inc. ($CERC) and a 10% Owner in Trevi Therapeutics, Inc. ($TRVI) and a Director in Epizyme, Inc. ($EPZM) and a Director in Adaptimmune Therapeutics PLC ($ADAP) and a 10% Owner in RHYTHM PHARMACEUTICALS, INC. ($RYTM) and a Director in IMARA Inc. ($IMRA) and a 10% Owner in Elastic N.V. ($ESTC) and a Director in Nightstar Therapeutics plc ($NITE) and a 10% Owner in Surface Oncology, Inc. ($SURF) and a 10% Owner in Mirum Pharmaceuticals, Inc. ($MIRM).
Address: 35 WEST WATKINS MILL ROAD GAITHERSBURG 20878 MD
Companies in which DAVID M MOTT is an Insider
Achaogen, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 5,215,128 shares
Current Value: $98,305,163
Latest Transaction: Dec 19 2016
$AKAO Market Capitalization: $541.33M
$AKAO Previous Close: $18.85
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Adaptimmune Therapeutics PLC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Director
Holdings: 19,500,000 shares
Current Value: $88,335,000
Latest Transaction: Jul 01 2020
$ADAP Market Capitalization: $321.36M
$ADAP Previous Close: $4.53
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
APPIAN CORP
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 2,724,202 shares
Latest Transaction: Feb 15 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARCA biopharma, Inc.
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Feb 27 2018
$ABIO Market Capitalization: $23.40M
$ABIO Previous Close: $2.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
ARDELYX, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 417,284 shares
Current Value: $4,610,988
Latest Transaction: Dec 10 2020
$ARDX Market Capitalization: $529.77M
$ARDX Previous Close: $11.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
AVEO PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 25,243,865 shares
Current Value: $15,398,758
Latest Transaction: Apr 08 2019
$AVEO Market Capitalization: $45.51M
$AVEO Previous Close: $0.61
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Care.com Inc
Industry: SERVICES-PERSONAL SERVICES [7200]
Position of DAVID M MOTT: 10% Owner
Holdings: 2,256,013 shares
Current Value: $21,071,161
Latest Transaction: Nov 08 2017
$CRCM Market Capitalization: $283.29M
$CRCM Previous Close: $9.34
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cascadian Therapeutics, Inc.
Industry: SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Latest Transaction: Mar 13 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Cerecor Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 594,245 shares
Current Value: $493,223
Latest Transaction: Oct 20 2015
$CERC Market Capitalization: $7.38M
$CERC Previous Close: $0.83
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Elastic N.V.
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 4,155,995 shares
Latest Transaction: Oct 10 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Epizyme, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 153,627 shares
Current Value: $1,851,205
Latest Transaction: Apr 01 2021
$EPZM Market Capitalization: $707.73M
$EPZM Previous Close: $12.05
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
GENOCEA BIOSCIENCES, INC.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: 10% Owner
Holdings: 7,225,676 shares
Current Value: $32,587,799
Latest Transaction: Jun 25 2019
$GNCA Market Capitalization: $129.13M
$GNCA Previous Close: $4.51
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
IMARA Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 0 shares
Latest Transaction: Mar 16 2020
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
INTERLEUKIN GENETICS INC
Industry: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
Position of DAVID M MOTT: 10% Owner
Holdings: 55,418,811 shares
Current Value: $5,541,881
Latest Transaction: Aug 02 2016
$ILIU Market Capitalization: $22.11M
$ILIU Previous Close: $0.10
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MEDIMMUNE INC /DE
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Vice Chairman and CEO
Holdings: 0 shares
Latest Transaction: Mar 10 2004
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mersana Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 9,109 shares
Latest Transaction: Jan 20 2021
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Mirum Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 3,736,243 shares
Latest Transaction: Jul 24 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
MULESOFT, INC
Industry: SERVICES-PREPACKAGED SOFTWARE [7372]
Position of DAVID M MOTT: 10% Owner
Holdings: 12,679,970 shares
Latest Transaction: May 09 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Nightstar Therapeutics plc
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Director
Holdings: 0 shares
Latest Transaction: Jun 07 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
NOVAVAX INC
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jun 22 2021
$NVAX Market Capitalization: $355.26M
$NVAX Previous Close: $1.31
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Ra Pharmaceuticals, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 80,658 shares
Current Value: $1,465,556
Latest Transaction: Oct 31 2016
$RARX Market Capitalization: $405.38M
$RARX Previous Close: $18.17
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Regulus Therapeutics Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 2,052,454 shares
Current Value: $2,873,436
Latest Transaction: Dec 26 2019
$RGLS Market Capitalization: $72.77M
$RGLS Previous Close: $1.40
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
RHYTHM PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 1,432,248 shares
Latest Transaction: Oct 10 2017
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Sorrento Tech, Inc.
Industry: LABORATORY ANALYTICAL INSTRUMENTS [3826]
Position of DAVID M MOTT: 10% Owner
Holdings: 0 shares
Current Value: $0
Latest Transaction: Sep 23 2016
$ROKA Market Capitalization: $8.04M
$ROKA Previous Close: $4.60
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Surface Oncology, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: 10% Owner
Holdings: 3,179,544 shares
Latest Transaction: Apr 23 2018
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
SYNLOGIC, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 4,228,940 shares
Current Value: $9,303,668
Latest Transaction: Jan 26 2018
$SYBX Market Capitalization: $45.84M
$SYBX Previous Close: $2.20
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
TESARO, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: Director
Holdings: 0 shares
Current Value: $0
Latest Transaction: Jan 22 2019
$TSRO Market Capitalization: $8.41B
$TSRO Previous Close: $162.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Tracon Pharmaceuticals, Inc.
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Position of DAVID M MOTT: 10% Owner
Holdings: 3,466,003 shares
Current Value: $17,156,715
Latest Transaction: Mar 27 2018
$TCON Market Capitalization: $64.02M
$TCON Previous Close: $4.95
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Trevi Therapeutics, Inc.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of DAVID M MOTT: 10% Owner
Holdings: 1,938,562 shares
Latest Transaction: May 13 2019
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD View transactions
Latest Insider Trading Transactions of DAVID M MOTT
Sentiment: All, AKAO, ADAP, APPN, ABIO, ARDX, AVEO, CRCM, CASC, CERC, ESTC, EPZM, GNCA, IMRA, ILIU, MEDI, MRSN, MIRM, MULE, NITE, NVAX, RARX, RGLS, RYTM, ROKA, SURF, SYBX, TSRO, TCON, TRVI
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 22 2021 | NVAX | NOVAVAX INC | MOTT DAVID M | Director | Option Exercise | A | 0.00 | 700 | 0 | 700 | |
| Jun 22 2021 | NVAX | NOVAVAX INC | MOTT DAVID M | Director | Option Exercise | A | 179.89 | 1,300 | 233,857 | 1,300 | |
| Apr 01 2021 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 8.71 | 2,727 | 23,752 | 153,627 | 150.9 K to 153.6 K (+1.81 %) |
| Jan 20 2021 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Option Exercise | A | 21.09 | 4,528 | 95,496 | 4,528 | |
| Jan 05 2021 | EPZM | Epizyme, Inc. | MOTT DAVID M | Director | Grant | A | 10.86 | 2,158 | 23,436 | 88,183 | 86 K to 88.2 K (+2.51 %) |
| Dec 15 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 486 | 0 | 9,595 | 9.1 K to 9.6 K (+5.34 %) |
| Dec 15 2020 | MRSN | Mersana Therapeuti ... | MOTT DAVID M | Director | Buy | J | 0.00 | 1,096 | 0 | 9,109 | 8 K to 9.1 K (+13.68 %) |